Company Filing History:
Years Active: 2024
Title: **Inventor Spotlight: Jia-Ying Yang**
Introduction
Jia-Ying Yang is a notable inventor based in San Clemente, California. He has made significant contributions to the field of ocular medicine through his innovative work on ocular implants. With a keen focus on developing advanced medical technologies, Yang has successfully patented a unique solution aimed at improving treatment options for various eye conditions.
Latest Patents
Jia-Ying Yang holds one patent titled "Bioerodible polyester polymer axitinib ocular implants and related methods of use." This groundbreaking patent outlines compositions that facilitate the sustained release of the small molecule tyrosine kinase inhibitor, axitinib, from a bioerodible polyester polymer implant. This innovation is particularly beneficial in treating ophthalmic conditions such as neovascular age-related macular degeneration and diabetic macular edema. The implant is designed to be injected via a small diameter needle, allowing for self-sealing scleral needle penetration, with the drug being released over a period ranging from one week to three years.
Career Highlights
Jia-Ying Yang's career is marked by his dedication to medical innovations. His work at Dose Medical Corporation has placed him at the forefront of developing cutting-edge ocular treatments. Through extensive research and experimentation, he has been able to bring his inventive ideas to fruition, contributing significantly to the advancement of medical technology.
Collaborations
Throughout his career, Yang has collaborated with other skilled professionals, including colleagues Patrick Michael Hughes and James Shiah. Together, they have fostered a productive environment that encourages the exchange of ideas and innovation in the medical field.
Conclusion
Jia-Ying Yang's contributions to ocular medicine through his patent on bioerodible polyester polymer implants showcase the power of innovative thinking in addressing medical challenges. His work not only enhances treatment options for patients but also exemplifies the ongoing advancements in medical technology that aim to improve health outcomes globally.